Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation

FEBS Letters

Volumn 584, Issue 6, 2010, Pages 1085-1090

  Zhou, Jianlin ^a   Qiao, Xi ^a   Xiao, Ling ^a   Sun, Wei ^a   Wang, Lin ^a   Li, Hong ^a   Wu, Yuan ^a   Ding, Xiaofeng ^a   Hu, Xiang ^a   Zhou, Chang ^a   Zhang, Jian ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

CCDC106; Nuclear localisation signal; P53; Protein degradation; Variant transcript

Indexed keywords

COILED COIL DOMAIN CONTAINING 106 PROTEIN; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; EXON; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN VARIANT;

CARRIER PROTEINS; CELL NUCLEUS; CLONING, MOLECULAR; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; NUCLEAR LOCALIZATION SIGNALS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77950371144     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.02.031     Document Type: Article

References (23)

1. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
2. Abida W.M., Nikolaev A., Zhao W., Zhang W., Gu W. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J. Biol. Chem. 2007, 282:1797-1804.
3. Wang W., El-Deiry W.S. Restoration of p53 to limit tumor growth. Curr. Opin. Oncol. 2008, 20:90-96.
4. Hainaut P., Soussi T., Shomer B., Hollstein M., Greenblatt M., Hovig E., Harris C.C., Montesano R. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res. 1997, 25:151-157.
5. Sigal A., Rotter V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 2000, 60:6788-6793.
6. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992, 358:80-83.
7. Laurie N.A., Donovan S.L., Shih C.S., Zhang J., Mills N., Fuller C., Teunisse A., Lam S., Ramos Y., Mohan A., Johnson D., Wilson M., Rodriguez-Galindo C., Quarto M., Francoz S., Mendrysa S.M., Guy R.K., Marine J.C., Jochemsen A.G., Dyer M.A. Inactivation of the p53 pathway in retinoblastoma. Nature 2006, 444:61-66.
8. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
9. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387:299-303.
10. Dornan D., Wertz I., Shimizu H., Arnott D., Frantz G.D., Dowd P., O'Rourke K., Koeppen H., Dixit V.M. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004, 429:86-92.
11. Leng R.P., Lin Y., Ma W., Wu H., Lemmers B., Chung S., Parant J.M., Lozano G., Hakem R., Benchimol S. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003, 112:779-791.
12. Yamasaki S., Yagishita N., Sasaki T., Nakazawa M., Kato Y., Yamadera T., Bae E., Toriyama S., Ikeda R., Zhang L., Fujitani K., Yoo E., Tsuchimochi K., Ohta T., Araya N., Fujita H., Aratani S., Eguchi K., Komiya S., Maruyama I., Higashi N., Sato M., Senoo H., Ochi T., Yokoyama S., Amano T., Kim J., Gay S., Fukamizu A., Nishioka K., Tanaka K., Nakajima T. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 2007, 26:113-122.
13. Boehme K.A., Blattner C. Regulation of p53-insights into a complex process. Crit. Rev. Biochem. Mol. Biol. 2009, 44:367-392.
14. Leung K.M., Po L.S., Tsang F.C., Siu W.Y., Lau A., Ho H.T., Poon R.Y. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. Cancer Res. 2002, 62:4890-4893.
15. Yan C., Lu D., Hai T., Boyd D.D. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J. 2005, 24:2425-2435.
16. Gronroos E., Terentiev A.A., Punga T., Ericsson J. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc. Natl. Acad. Sci. USA 2004, 101:12165-12170.
17. Lim S.T., Chen X.L., Lim Y., Hanson D.A., Vo T.T., Howerton K., Larocque N., Fisher S.J., Schlaepfer D.D., Ilic D. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol. Cell. 2008, 29:9-22.
18. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., Timm J., Mintzlaff S., Abraham C., Bock N., Kietzmann S., Goedde A., Toksoz E., Droege A., Krobitsch S., Korn B., Birchmeier W., Lehrach H., Wanker E.E. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968.
19. Zhou J., Fan C., Zhong Y., Liu Y., Liu M., Zhou A., Ren K., Zhang J. Genomic organization, promoter characterization and roles of Sp1 and AP-2 in the basal transcription of mouse PDIP1 gene. FEBS Lett. 2005, 579:1715-1722.
20. Ding X., Fan C., Zhou J., Zhong Y., Liu R., Ren K., Hu X., Luo C., Xiao S., Wang Y., Feng D., Zhang J. GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation. Nucleic Acids Res. 2006, 34:2570-2578.
21. Nair R., Rost B. Mimicking cellular sorting improves prediction of subcellular localization. J. Mol. Biol. 2005, 348:85-100.
22. Maass N., Rosel F., Schem C., Hitomi J., Jonat W., Nagasaki K. Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer. Cancer Lett. 2002, 185:219-223.
23. Kuo P.C., Tsao Y.P., Chang H.W., Chen P.H., Huang C.W., Lin S.T., Weng Y.T., Tsai T.C., Shieh S.Y., Chen S.L. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor. Cancer Res. 2009, 69:8877-8885.